Welcome
Innovative Biopharmaceutical and Healthcare Consulting Services
Our consulting services revolutionize how you engage in biopharmaceutical and healthcare policy, health disparities, poverty
Our consulting services revolutionize how you engage in biopharmaceutical and healthcare policy, health disparities, poverty
At Conquest Advisors, we have years of experience offering consulting services for the healthcare & biopharmaceutical industry. We specialize in policy, economics, medical affairs, strategic planning, public affairs, and government relations. Our expertise can help take your business to the next level.
Our team at Conquest Advisors comprises highly skilled professionals with diverse backgrounds in healthcare and biopharmaceutical policy, economics, and public affairs consulting services. We work together to provide our clients with tailored solutions that meet their unique needs. Meet our team and learn more about our areas of expertise.
At Conquest Advisors, our mission is to serve our clients by leveraging our expertise in economics, medical, policy, government affairs, advocacy, and media so that they may fully realize their investment in developing life-changing biopharmaceuticals and devices for patients.
We love our clients. Our seasoned consultants are ready to serve.
Alexandria, Virginia, United States
Pioneer Senior Fellows Dr. William Smith, PhD and Dr. Robert Popovian, PharmD, highlight updates and new data in the Institute's first-of-its-kind PLSI 50-state mapping tool and database on 340B that uncovers the troubling way in which hospitals and covered entities leverage unlimited pharmacy contracts under the program. Drs. Smith and Popovian also share a preview of a forthcoming PLSI tool that will investigate and track the impact of the Inflation Reduction Act on patient access and prescription drug formularies.
Insightful discussion on the impact of the Inflation Reduction Act's maximum fair price on patients
Panelists, Eric Hargan, former Deputy Secretary of the Department of Health and Human Services, and Dr. Robert Popovian, Senior Health Policy Fellow at the Progressive Policy Institute, will lend their expertise to discussions ranging from FDA approval processes, to march-in rights, to the Inflation Reduction Act's pharmaceutical provisions. Moderated by NTU President Pete Sepp, this session promises a lively discussion about the nexus between health care and taxpayers.
Pioneer Institute's webinar on gene replacement therapy (GRT) featured esteemed panelists Dr. Robert Popovian, Senior Visiting Health Policy Fellow at Pioneer Institute; Dr. William Smith, Senior Fellow & Director of the Pioneer Life Sciences Initiative at Pioneer Institute; and Dr. Anne M. Sydor, Director of Research Development and Communications at the Global Healthy Living Foundation.
Join Dr. Robert Popovian and Ben Blanc for a special live episode from the World Vaccine Congress in Washington, DC, where they delve into the latest developments in vaccine policy and economic research. This episode spotlights the congress's role as a vital hub for collaboration and innovation in the vaccine industry.
In this webinar you will learn how formulary exclusions impact a patient's care and well-being. You will also learn about original research conducted by the GHLF researchers regarding formulary exclusions and our GHLF's plans to raise awareness concerning this important issue with policymakers.
Big or Small, Red or Blue – States With Laws Protecting Patient Assistance Programs Have Not Seen Health Insurance Premium Hikes
340B drug discount program has veered from its original mission to help low-income patients access medicine, and has instead grown into a profit revenue stream for hospitals.
How PBMs inflate healthcare spending in the U.S.
How PBMs steel patient assistance program funding to benefit their bottom line.
Give customers a reason to do business with you.
Copyright © 2024 Conquest Advisors - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.